PHILADELPHIA, Sept. 3,
2024 /PRNewswire/ -- Carisma Therapeutics Inc.
(Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage
biopharmaceutical company focused on discovering and developing
innovative immunotherapies, today announced that Steven Kelly,
President and Chief Executive Officer, will participate in the
following upcoming conferences:
Baird 2024 Global Healthcare Conference
- Tuesday, September 10 at
12:50 PM ET
- New York, NY
H.C. Wainwright 26th Annual Global Investment
Conference
- Wednesday, September 11 at
1:30 PM ET
- New York, NY
Chardan's 8th Annual Genetic Medicines
Conference
- Monday, September 30 at
4:00 PM ET
- New York, NY
The Cell & Gene Meeting on the Mesa
- Monday, October 7 at 9:30 AM MST
- Phoenix, AZ
Live webcasts will be available on the Company's Investor Events
webpage. A replay of the webcasts, when available, will be archived
for a limited time following the event.
About Carisma
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical
company focused on utilizing our proprietary macrophage and
monocyte cell engineering platform to develop transformative
immunotherapies to treat cancer and other serious diseases. We have
created a comprehensive, differentiated proprietary cell therapy
platform focused on engineered macrophages and monocytes, cells
that play a crucial role in both the innate and adaptive immune
response. Carisma is headquartered in Philadelphia, PA. For more information, please
visit www.carismatx.com.
Investors:
Shveta
Dighe
Head of Investor Relations
investors@carismatx.com
Media Contact:
Julia
Stern
(763) 350-5223
jstern@realchemistry.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-at-upcoming-conferences-302235237.html
SOURCE Carisma Therapeutics Inc.